Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library-Reference-Cited by-同舟云学术

Identification of an anti–SARS–CoV-2 receptor-binding domain–directed human monoclonal antibody from a naïve semisynthetic library

Published:2020-09 Issue:36 Volume:295 Page:12814-12821
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Parray Hilal Ahmad,Chiranjivi Adarsh Kumar,Asthana Shailendra,Yadav Naveen,Shrivastava Tripti,Mani Shailendra,Sharma Chandresh,Vishwakarma Preeti^ORCID,Das Supratik^ORCID,Pindari Kamal,Sinha Subrata,Samal Sweety,Ahmed Shubbir,Kumar Rajesh

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference29 articles.

1. COVID-19: immunology and treatment options;Felsenstein;Clin. Immunol,2020

2. History and practice: antibodies in infectious diseases;Hey;Microbiol. Spectr,2015

3. Antibody-based therapeutic interventions: possible strategy to counter chikungunya viral infection;Kumar;Appl. Microbiol. Biotechnol,2020

4. The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS–CoV-2 patients;Premkumar;Sci. Immunol,2020

5. The convalescent sera option for containing COVID-19;Casadevall;J. Clin. Invest,2020

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Detection strategies of infectious diseases via peptide-based electrochemical biosensors;Bioelectrochemistry;2024-12

2. Phage Display as a Medium for Target Therapy Based Drug Discovery, Review and Update;Molecular Biotechnology;2024-06-01

3. Expression, purification, and study on the efficiency of a new potent recombinant scFv antibody against the SARS-CoV-2 spike RBD in E. coli BL21;Protein Expression and Purification;2023-03

4. State of the art in epitope mapping and opportunities in COVID-19;Future Science OA;2023-01

5. A broadly neutralizing monoclonal antibody overcomes the mutational landscape of emerging SARS-CoV-2 variants of concern;PLOS Pathogens;2022-12-12